Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
This completed clinical trial evaluates urinary isoprostanes as a biomarker for disease assessment in children with inflammatory bowel disea…
-
FDA approval · 2016-01-26FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for mesalamine (Teva Pharmaceuticals USA, Inc.), enabling a modification to the product labeling…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating once-daily versus thrice-daily dosing of mesalamine granules in active ulcerative colitis has completed. The sponso…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis
A completed clinical trial comparing conventional colonoscopy to endoscopic autofluorescence imaging (AFI) and narrow-band imaging (NBI) for…
-
CLINICAL_TRIALS research · 2016-01-14Clinical Trial Update: Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
This completed UCLA-sponsored study used multimodal MRI to examine differences in brain structure and resting-state function.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis [Phase 4]
Phase 4 trial evaluating once-daily versus twice-daily mesalamine to induce remission in pediatric ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Responsiveness of Endoscopic Evaluation in UC
A completed clinical trial sponsored by the University of Western Ontario assessing the responsiveness of endoscopic evaluation in ulcerativ…
-
FDA approval · 2015-11-30FDA Approved: BUDESONIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Budesonide from Chartwell RX, LLC, authorizing a change to an existing generic product.
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
FDA approval · 2015-11-20FDA Approved: BUDESONIDE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for Budesonide filed by Rite Aid Corporation (ANDA078949), confirming an updated approval for this g…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of GLPG1205 in active ulcerative colitis has completed, providing efficacy and safety res…
-
CLINICAL_TRIALS research · 2015-11-16Clinical Trial Update: Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
This clinical trial update describes a qualitative study examining adherence to topical mesalamine in patients with ulcerative colitis.
-
CLINICAL_TRIALS other · 2015-11-06Clinical Trial Update: Decentralized Dietary UC Pilot Trial [NA]
An update on a decentralized dietary ulcerative colitis pilot trial; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
This clinical trial studied the stability of anti-glycan antibodies in a Saint-Etienne inflammatory bowel disease cohort and has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis [Phase 3]
A Phase 3 trial evaluating infliximab in Chinese patients with active ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2015-10-29Clinical Trial Update: Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis
A completed prospective, multicenter observational survey examining the therapeutic care of patients with mild to moderate ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Adacolumn in Refractory UC Patients Trial [Phase 4]
Phase 4 trial update showing the completion of a study evaluating Adacolumn in patients with active moderate ulcerative colitis.
-
CLINICAL_TRIALS research · 2015-10-14Clinical Trial Update: Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease [Phase 3]
A Phase 3 trial is evaluating the efficacy of fecal microbiota transplantation for inflammatory bowel disease. The study includes ulcerative…
-
CLINICAL_TRIALS research · 2015-10-14Clinical Trial Update: Monroe County Inflammatory Bowel Disease (IBD) Registry
A completed update for the Monroe County Inflammatory Bowel Disease (IBD) Registry, covering inflammatory bowel disease including Crohn's di…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Study of MDX-1100 in Subjects With Active Ulcerative Colitis [Phase 2]
Phase 2 study of MDX-1100 in active ulcerative colitis conducted by Bristol-Myers Squibb has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
This update reports the completion of a clinical trial evaluating endoscopic ultrasound as a method to assess disease activity in ulcerative…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Mesalazine (PENTASA®) in Ulcerative Colitis
A completed clinical trial update for Mesalazine (PENTASA) in ulcerative colitis, provided by Ferring Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Randomized-controlled Trial of Yoga for Ulcerative Colitis [NA]
A completed randomized-controlled trial evaluating yoga as an intervention for ulcerative colitis, sponsored by Universität Duisburg-Essen. …
-
FDA approval · 2015-09-18FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
FDA granted a supplemental approval for sulfasalazine from Sunrise Pharmaceutical, Inc.
-
CLINICAL_TRIALS research · 2015-09-18Clinical Trial Update: Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer [NA]
Completed clinical trial evaluating the effects of eicosapentaenoic acid in subjects with ulcerative colitis who are at high risk for colore…